IGC Pharma (IGC) Exchange Rate Effect (2010 - 2025)
IGC Pharma (IGC) posted quarterly Exchange Rate Effect of $5000.0 for Q3 2025, up 145.45% year-over-year from $2037.0 in Q3 2024, and down 80.0% quarter-over-quarter from $25000.0 in Q2 2025.
IGC Pharma (IGC) Exchange Rate Effect (2010 - 2025) Analysis & Trends
IGC Pharma (IGC) has reported Exchange Rate Effect for 16 consecutive years, with $5000.0 the latest figure, recorded in Q3 2025.
- In Q3 2025, Exchange Rate Effect rose 145.45% year-over-year to $5000.0; the TTM figure through Sep 2025 stood at $32000.0 (up 633.33% YoY), while the FY2026 annual figure was -$10000.0, down 42.86% from the prior year.
- Exchange Rate Effect eased to $5000.0 in Q3 2025 per IGC's latest filing, from $25000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $25000.0 in Q2 2025 and bottomed at -$52000.0 in Q2 2022.
- Historically, Exchange Rate Effect has averaged -$5111.1 across 5 years, with a median of $1000.0 in 2023.
- Annual changes were most pronounced in 2022 — Exchange Rate Effect sank 3900.0% — and 2025, when it surged 1150.0%.
- IGC Pharma's Exchange Rate Effect stood at $14000.0 in 2021, then plunged by 192.86% to -$13000.0 in 2022, then jumped by 107.69% to $1000.0 in 2023, then plunged by 1200.0% to -$11000.0 in 2024, then soared by 145.45% to $5000.0 in 2025.
- Business Quant data shows IGC's Exchange Rate Effect at $5000.0 in Q3 2025, $25000.0 in Q2 2025, and $2000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -2.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 19.84 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | -2.45 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -287,000.00 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.63 Mn |
| 10 | IGC Pharma | 27.20 Mn | 26.94 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 5,000.00 |
| Sep 30, 2025 | 5,000.00 |
| Jun 30, 2025 | 25,000.00 |
| Jun 30, 2025 | 25,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Sep 30, 2024 | -11,000.00 |
| Sep 30, 2024 | -11,000.00 |
| Jun 30, 2024 | 2,000.00 |
| Jun 30, 2024 | 2,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Dec 31, 2023 | 1,000.00 |
| Dec 31, 2023 | 1,000.00 |
| Sep 30, 2023 | -10,000.00 |
| Sep 30, 2023 | -10,000.00 |
| Jun 30, 2023 | 1,000.00 |
| Jun 30, 2023 | 1,000.00 |
| Mar 31, 2023 | 11,000.00 |
| Mar 31, 2023 | 11,000.00 |